1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine has been researched along with Brain Vascular Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiguchi, I; Kimura, J; Nakamura, S | 1 |
1 other study(ies) available for 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine and Brain Vascular Disorders
Article | Year |
---|---|
The histochemical demonstration of MPTP oxidation in the postmortem human striatum.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Caudate Nucleus; Cerebrovascular Disorders; Clorgyline; Corpus Striatum; Dopamine Agents; Female; Glial Fibrillary Acidic Protein; Histocytochemistry; Humans; Male; Monoamine Oxidase; Neuroglia; Oxidation-Reduction; Putamen; Selegiline | 1993 |